CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $52.65 million. The enterprise value is $17.41 million.

Market Cap	52.65M
Enterprise Value	17.41M

Important Dates

The next estimated earnings date is Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 8.70 million shares outstanding. The number of shares has increased by 113.68% in one year.

Current Share Class	8.70M
Shares Outstanding	8.70M
Shares Change (YoY)	+113.68%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	33.43%
Owned by Institutions (%)	16.43%
Float	4.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.66
Forward PS	n/a
PB Ratio	1.52
P/TBV Ratio	1.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.78

Current Ratio	9.78
Quick Ratio	9.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -93.42% and return on invested capital (ROIC) is -65.47%.

Return on Equity (ROE)	-93.42%
Return on Assets (ROA)	-56.19%
Return on Invested Capital (ROIC)	-65.47%
Return on Capital Employed (ROCE)	-60.45%
Revenue Per Employee	$620,548
Profits Per Employee	-$1.24M
Employee Count	15
Asset Turnover	0.40
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-67.16%
50-Day Moving Average	8.26
200-Day Moving Average	8.06
Relative Strength Index (RSI)	32.97
Average Volume (20 Days)	142,601

Short Selling Information

The latest short interest is 271,862, so 3.12% of the outstanding shares have been sold short.

Short Interest	271,862
Short Previous Month	279,020
Short % of Shares Out	3.12%
Short % of Float	5.51%
Short Ratio (days to cover)	1.79

Income Statement

In the last 12 months, CervoMed had revenue of $9.31 million and -$18.67 million in losses. Loss per share was -$2.14.

Revenue	9.31M
Gross Profit	-11.51M
Operating Income	-20.94M
Pretax Income	-5.04M
Net Income	-18.67M
EBITDA	n/a
EBIT	-20.94M
Loss Per Share	-$2.14

Full Income Statement

Balance Sheet

The company has $35.24 million in cash and n/a in debt, giving a net cash position of $35.24 million or $4.05 per share.

Cash & Cash Equivalents	35.24M
Total Debt	n/a
Net Cash	35.24M
Net Cash Per Share	$4.05
Equity (Book Value)	34.63M
Book Value Per Share	3.98
Working Capital	34.63M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -123.69%, with operating and profit margins of -224.91% and -200.58%.

Gross Margin	-123.69%
Operating Margin	-224.91%
Pretax Margin	-200.58%
Profit Margin	-200.58%
EBITDA Margin	n/a
EBIT Margin	-224.91%
FCF Margin	n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-113.68%
Shareholder Yield	-113.68%
Earnings Yield	-35.46%
FCF Yield	n/a

Analyst Forecast

The average price target for CervoMed is $25.57, which is 322.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.57
Price Target Difference	322.65%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	13.41%
EPS Growth Forecast (5Y)	-15.25%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of 12.45 and a Piotroski F-Score of 1.

Altman Z-Score	12.45
Piotroski F-Score	1